Xin Hui
Director/Board Member bij CHEMPARTNER PHARMATECH CO., LTD.
Profiel
Xin Hui is the founder of Yingli Pharma Ltd.
He currently holds multiple positions, including Chairman & Chief Executive Officer at Shangpharma Corp., Chairman at ShangPharma Innovation, Inc., Chairman at Kaihui Pharmaceutical (Shanghai) Co., Ltd., Chairman at Quantum Bio, Director at ChemPartner PharmaTech Co., Ltd., Managing Director at Pandect Bioventures LP, and Director at Aprinoia Therapeutics, Inc. Previously, he served as Chairman at Shanghai ChemPartner Co., Ltd., Investment Manager at Ceres Ventures, Inc., and Project Manager at China Innovation Center for Life Science.
Mr. Hui obtained a graduate degree from Tulane University (Louisiana), an MBA from New York University, and an undergraduate degree from Oregon State University.
Actieve functies van Xin Hui
| Bedrijven | Functie | Begin |
|---|---|---|
| CHEMPARTNER PHARMATECH CO., LTD. | Director/Board Member | 01-01-2021 |
Shangpharma Corp.
 Shangpharma Corp. Pharmaceuticals: MajorHealth Technology Shangpharma Corp. provides pharmaceutical and biotechnology research outsourcing services. It offers various integrated services across the drug discovery and development process to international and chinese pharmaceutical and biotechnology companies, and academic and research institutions. The company was founded by Michael Xin Hui and Wenjuan Xiao in 2002 and is headquartered in Shanghai, China. | Chief Executive Officer | 01-09-2007 |
Kaihui Pharmaceutical (Shanghai) Co., Ltd.
 Kaihui Pharmaceutical (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Kaihui Pharmaceutical (Shanghai) Co., Ltd. was founded in 2008 and provides biomedical technology services. The private company is based in Shanghai, China. | Chairman | - |
ShangPharma Innovation, Inc.
 ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | Chairman | - |
| Quantum Bio | Chairman | 01-06-2019 |
Aprinoia Therapeutics, Inc. /US/
 Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Director/Board Member | 01-10-2022 |
Pandect Bioventures LP
 Pandect Bioventures LP Investment ManagersFinance Pandect Bioventures LP invests in companies located in the United States. The fund target companies operating in the fields of health technology. It provides financing for seed and early stage capital requirements. | Chief Executive Officer | - |
| Yingli Pharma Ltd. | Founder | - |
Eerdere bekende functies van Xin Hui
| Bedrijven | Functie | Einde |
|---|---|---|
| CERES VENTURES, INC. | Chief Investment Officer | 01-01-2000 |
| ░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░ ░░░░░░ ░░░ ░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Opleiding van Xin Hui
| Tulane University (Louisiana) | Graduate Degree |
| New York University | Masters Business Admin |
| Oregon State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CHEMPARTNER PHARMATECH CO., LTD. | Commercial Services |
| CERES VENTURES, INC. | Health Services |
| Bedrijven in privébezit | 9 |
|---|---|
Shangpharma Corp.
Shangpharma Corp. Pharmaceuticals: MajorHealth Technology Shangpharma Corp. provides pharmaceutical and biotechnology research outsourcing services. It offers various integrated services across the drug discovery and development process to international and chinese pharmaceutical and biotechnology companies, and academic and research institutions. The company was founded by Michael Xin Hui and Wenjuan Xiao in 2002 and is headquartered in Shanghai, China. | Health Technology |
Shanghai ChemPartner Co., Ltd.
 Shanghai ChemPartner Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai ChemPartner Co., Ltd. operates as a contract research organization. It provides chemistry, biology, pharmacology, DMPK, process R&D, pre-formulation, and analytical development services to global pharmaceutical and biotech companies. The company was founded in 2003 and is headquartered in Shanghai, China. | Commercial Services |
| China Innovation Center for Life Science | |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | Finance |
Pandect Bioventures LP
Pandect Bioventures LP Investment ManagersFinance Pandect Bioventures LP invests in companies located in the United States. The fund target companies operating in the fields of health technology. It provides financing for seed and early stage capital requirements. | Finance |
Kaihui Pharmaceutical (Shanghai) Co., Ltd.
Kaihui Pharmaceutical (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Kaihui Pharmaceutical (Shanghai) Co., Ltd. was founded in 2008 and provides biomedical technology services. The private company is based in Shanghai, China. | Commercial Services |
| Quantum Bio | |
| Yingli Pharma Ltd. | |
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Health Technology |
